Alterity Therapeutics Limited (NASDAQ:ATHE) is one of the best performing ASX stocks in 2025. On September 15, the company shared data from its Phase 2 clinical trial of the drug ATH434-201 at the ...

The latest announcement is out from Alterity Therapeutics ( (AU:ATH) ).

The human body requires protein as one of its fundamental nutritional elements, and it is known as the 'building block of the ...

Hameroff points to studies that demonstrate that, in humans, applying sub-thermal tFUS to the hippocampus of Alzheimer’s ...

See why Teva Pharmaceutical Industries Limited is shifting the CNS market with Austedo sales growth, new clinical data, and ...

The authors of a controversial 2022 paper that claimed to measure neuronal activity using functional MRI retracted their work ...

A recent study tracking over 430,000 people found that the RSV vaccine (as well as the shingles vaccine) was associated with a reduced risk of dementia over 18 months compared with those who received ...

After menopause, women with MS show accelerated loss of volume in brain structures associated with memory, attention, and problem-solving.

Around 5,000 Americans are diagnosed with amyotrophic lateral sclerosis (ALS) each year. About half of patients die within 14 ...

New research presented today at the 41st Congress of the European Committee for Treatment and Research in Multiple Sclerosis ...

A study of the effects of repetitive impacts to the head during one season of football found that the smooth pursuit velocity ...